Scarica l'app Stockscreener
3.47
7.10%
0.23
Pre-mercato:
3.49
0.02
+0.58%
Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie
Fed Watch: Can Aquestive Therapeutics Inc grow without external funding2025 Momentum Check & AI Forecasted Entry/Exit Points - baoquankhu1.vn
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - TMX Newsfile
INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - GuruFocus
Jim Cramer on Aquestive Therapeutics: “I’m not sure if they deserve the benefit of the doubt” - MSN
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc.AQST - yourwyominglink.com
What’s the RSI of Aquestive Therapeutics Inc. stockJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - mfd.ru
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - FinancialContent
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc.AQST - marketscreener.com
Jim Cramer on Aquestive Therapeutics: “I’m Not Sure If They Deserve the Benefit of the Doubt” - Insider Monkey
Jim Cramer on Crinetics: “That’s a Better Spec Than Aquestive” - Yahoo Finance
Jim Cramer Recently Looked at These 25 Stocks - Insider Monkey
AQUESTIVE ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
How does Aquestive Therapeutics Inc. score in quality rankingsWeekly Loss Report & Technical Confirmation Alerts - bollywoodhelpline.com
Faruqi & Faruqi Investigates Aquestive Therapeutics After 40% Stock Plunge Due to FDA Concerns - Intellectia AI
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - PR Newswire
Shorts Report: Is Aquestive Therapeutics Inc backed by strong institutional buyingQuarterly Investment Review & Verified Technical Trade Signals - baoquankhu1.vn
Kaplan Fox & Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations - NewMediaWire
About Us - FinancialContent
Peering Into Aquestive Therapeutics Inc's Recent Short Interest - Benzinga
A Look At Aquestive Therapeutics (AQST) Valuation After Anaphylm Regulatory Update And FDA Feedback - Sahm
Commonwealth Equity Services LLC Takes $5.92 Million Position in Aquestive Therapeutics, Inc. $AQST - MarketBeat
Here's Why Aquestive Therapeutics (AQST) Is a Great 'Buy the Bottom' Stock Now - sharewise.com
Rate Hike: Is Aquestive Therapeutics Inc gaining market share2025 Price Momentum & Low Drawdown Trading Strategies - baoquankhu1.vn
Levi & Korsinsky Investigates Possible Securities Fraud by Aquestive Therapeutics, Inc. (AQST) - marketscreener.com
Trend Review: How does Aquestive Therapeutics Inc score in quality rankingsJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aquestive Therapeutics Inc. (AQST) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aquestive Therapeutics Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation - TradingView
Aquestive drops as FDA flags issues in Anaphylm marketing application - MSN
Aquestive Therapeutics: Anaphylm Will Probably Survive This Regulatory Hurdle - Seeking Alpha
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - marketscreener.com
Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround - Yahoo Finance
Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies in Anaphylm FilingWhat's Changed - Sahm
Assessing Aquestive Therapeutics (AQST) Valuation After FDA Flags Anaphylm Application Deficiencies - Yahoo Finance
Oklo, Applied Digital, Opendoor Technologies, Vistra, Aquestive Therapeutics: Stocks making the biggest moves today - MSN
Why Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies In Anaphylm Application – And What's Next - Yahoo Finance
Benzinga Bulls And Bears: Chevron, Palantir, Aquestive — And Real Estate Stocks Plummet - Benzinga
Lake Street Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST) - The Globe and Mail
AQST Stock Plunges On An FDA Setback For Its Allergy Drug – Here’s What Has Changed - Stocktwits
Sector Update: Health Care - MarketScreener
Aquestive Therapeutics Stock Dips Amid Financial Challenges - StocksToTrade
Oklo, Applied Digital, Opendoor Technologies, Vistra, Aquestive Therapeutics: Stocks Making The Biggest Moves Today - Stocktwits
INVESTOR ALERT: Investigation of Aquestive Therapeutics, Inc. (AQST) by Holzer & Holzer, LLC - GlobeNewswire
Is Aquestive Therapeutics Inc. stock oversold or undervalued2025 Price Targets & Accurate Entry and Exit Point Alerts - ulpravda.ru
0.51%
9.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):